Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6465662 | 0.87 | EPHX2 (0.34) | HSD11B1HSD11B2 | |
| SCHEMBL1735132 | 0.71 | GRIN2D (0.32) | — | |
| SCHEMBL30498964 | 0.68 | — | — | |
| SCHEMBL29033699 | 0.67 | EPHX2 (0.38) | HSD11B1 | |
| SCHEMBL1735092 | 0.67 | EPHX2 (0.40) | — | |
| SCHEMBL19808662 | 0.63 | NPC1 (0.39) | HSD11B1HSD11B2 | |
| SCHEMBL19808587 | 0.63 | LMNA (0.51) | HSD11B1HSD11B2 | |
| SCHEMBL14190758 | 0.63 | HSD11B1 (0.30) | HSD11B1HSD11B2 | |
| SCHEMBL19808243 | 0.63 | EPHX2 (0.40) | HSD11B1HSD11B2 | |
| SCHEMBL20724768 | 0.63 | EPHX2 (0.40) | HSD11B1HSD11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1534427-B1 | AN ADAMANTYL CATALYST SYSTEM | LUCITE INT UK LTD (GB) | 2009-10-21 | — | — | EP | disclosed |
| US-7371705-B2 | Phospha-adamantane(s) catalytic system | LUCITE INTERNATIONAL UK LIMITED (GB) | 2008-05-13 | — | — | US | disclosed |
| US-20060106259-A1 | Phospha-adamantane(s) catalytic system | LUCITE INTERNATIONAL UK LIMITED (GB) | 2006-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060106259-A1 | Phospha-adamantane(s) catalytic system | ADORA2A, ADORA3, ADGRE5 | HSD11B1 2715/4885HSD11B2 1860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.